The market for radioligand therapy market is expected to increase at a compound annual growth rate (CAGR) of 9.41% from 2024 to 2034, from its estimated valuation of USD 7.44 billion in 2023 to USD 20.01 million by 2034. Because of its targeted approach, which optimizes treatment efficacy while minimizing side effects, its versatility in treating different types of cancer, its promise for...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek